219 related articles for article (PubMed ID: 37682144)
1. The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review.
Xian F; Zhao C; Huang C; Bie J; Xu G
Medicine (Baltimore); 2023 Sep; 102(36):e35038. PubMed ID: 37682144
[TBL] [Abstract][Full Text] [Related]
2. Targeting Cdc20 for cancer therapy.
Jeong SM; Bui QT; Kwak M; Lee JY; Lee PC
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188824. PubMed ID: 36243246
[TBL] [Abstract][Full Text] [Related]
3. CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies.
Bruno S; Ghelli Luserna di Rorà A; Napolitano R; Soverini S; Martinelli G; Simonetti G
J Exp Clin Cancer Res; 2022 Apr; 41(1):159. PubMed ID: 35490245
[TBL] [Abstract][Full Text] [Related]
4. Current Progress and Perspectives of CDC20 in Female Reproductive Cancers.
Ni K; Hong L
Curr Mol Med; 2023; 23(3):193-199. PubMed ID: 35319365
[TBL] [Abstract][Full Text] [Related]
5. Targeting Cdc20 as a novel cancer therapeutic strategy.
Wang L; Zhang J; Wan L; Zhou X; Wang Z; Wei W
Pharmacol Ther; 2015 Jul; 151():141-51. PubMed ID: 25850036
[TBL] [Abstract][Full Text] [Related]
6. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
Alfarsi LH; Ansari RE; Craze ML; Toss MS; Masisi B; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Dec; 178(3):535-544. PubMed ID: 31471836
[TBL] [Abstract][Full Text] [Related]
7. APC(Cdc20) suppresses apoptosis through targeting Bim for ubiquitination and destruction.
Wan L; Tan M; Yang J; Inuzuka H; Dai X; Wu T; Liu J; Shaik S; Chen G; Deng J; Malumbres M; Letai A; Kirschner MW; Sun Y; Wei W
Dev Cell; 2014 May; 29(4):377-91. PubMed ID: 24871945
[TBL] [Abstract][Full Text] [Related]
8. CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression.
Yang C; Ge Y; Zang Y; Xu M; Jin L; Wang Y; Xu X; Xue B; Wang Z; Wang L
Apoptosis; 2023 Dec; 28(11-12):1584-1595. PubMed ID: 37535214
[TBL] [Abstract][Full Text] [Related]
9. CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling pathway.
Chu Z; Zhang X; Li Q; Hu G; Lian CG; Geng S
Int J Oncol; 2019 May; 54(5):1534-1544. PubMed ID: 30816486
[TBL] [Abstract][Full Text] [Related]
10. CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.
Yang G; Wang G; Xiong Y; Sun J; Li W; Tang T; Li J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33907851
[TBL] [Abstract][Full Text] [Related]
11. MYBL2 in synergy with CDC20 promotes the proliferation and inhibits apoptosis of gastric cancer cells.
Deng Q; Wu L; Li Y; Zou L
Adv Clin Exp Med; 2021 Sep; 30(9):957-966. PubMed ID: 34358419
[TBL] [Abstract][Full Text] [Related]
12. Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells.
Shang G; Ma X; Lv G
Cell Cycle; 2018; 17(1):43-52. PubMed ID: 28980876
[TBL] [Abstract][Full Text] [Related]
13. Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.
Li J; Gao JZ; Du JL; Huang ZX; Wei LX
Int J Oncol; 2014 Oct; 45(4):1547-55. PubMed ID: 25069850
[TBL] [Abstract][Full Text] [Related]
14. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
15. Cdc20/p55 mediates the resistance to docetaxel in castration-resistant prostate cancer in a Bim-dependent manner.
Wu F; Lin Y; Cui P; Li H; Zhang L; Sun Z; Huang S; Li S; Huang S; Zhao Q; Liu Q
Cancer Chemother Pharmacol; 2018 Jun; 81(6):999-1006. PubMed ID: 29605876
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive analysis of CDC20 overexpression in common malignant tumors from multiple organs: its correlation with tumor grade and stage.
Gayyed MF; El-Maqsoud NM; Tawfiek ER; El Gelany SA; Rahman MF
Tumour Biol; 2016 Jan; 37(1):749-62. PubMed ID: 26245990
[TBL] [Abstract][Full Text] [Related]
17. Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells.
Zhang Q; Huang H; Liu A; Li J; Liu C; Sun B; Chen L; Gao Y; Xu D; Su C
EBioMedicine; 2019 Apr; 42():397-407. PubMed ID: 30904606
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of CDC20 suppressed cell proliferation, induced apoptosis, triggered cell cycle arrest in osteosarcoma cells, and enhanced chemosensitivity to cisplatin.
Gao Y; Guo C; Fu S; Cheng Y; Song C
Neoplasma; 2021 Mar; 68(2):382-390. PubMed ID: 33118830
[TBL] [Abstract][Full Text] [Related]
19. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
[TBL] [Abstract][Full Text] [Related]
20. CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
Ding Y; Yu S; Bao Z; Liu Y; Liang T
J Neurooncol; 2017 May; 133(1):87-95. PubMed ID: 28432586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
